APA

Cogan D. A., Aungst R., Breinlinger E. C., Fadra T., Goldberg D. R., Hao M. H., Kroe R., Moss N., Pargellis C., Qian K. C. & Swinamer A. D. (20080709). Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. : Bioorganic & medicinal chemistry letters.

Chicago

Cogan D A, Aungst R, Breinlinger E C, Fadra T, Goldberg D R, Hao M H, Kroe R, Moss N, Pargellis C, Qian K C and Swinamer A D. 20080709. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. : Bioorganic & medicinal chemistry letters.

Harvard

Cogan D. A., Aungst R., Breinlinger E. C., Fadra T., Goldberg D. R., Hao M. H., Kroe R., Moss N., Pargellis C., Qian K. C. and Swinamer A. D. (20080709). Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. : Bioorganic & medicinal chemistry letters.

MLA

Cogan D A, Aungst R, Breinlinger E C, Fadra T, Goldberg D R, Hao M H, Kroe R, Moss N, Pargellis C, Qian K C and Swinamer A D. Structure-based design and subsequent optimization of 2-tolyl-(1,2,3-triazol-1-yl-4-carboxamide) inhibitors of p38 MAP kinase. : Bioorganic & medicinal chemistry letters. 20080709.